| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-05 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
4e-05 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
5e-05 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
6e-05 |
| mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |